• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
ShareholdingPattern

2022 – 2023

Q1 (April to June, 2022)
Financial
Download
Q2 ( July to September, 2022)
Financial
Download
Q3 ( October to December, 2022)
Financial
Download
Q4 ( January to March, 2023)
Financial
Download

2021 – 2022

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (September to December)
Financial
Download
Q4 (January to March, 2022)
Financial
Download

2020 – 2021

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (October to December)
Financial
Download
Q4 (January to March)
Financial
Download

2019 – 2020

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (October to December)
Financial
Download
Q4 (January to March)
Financial
Download

2018 – 2019

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (October to December)
Financial
Download
Q4 (January to March)
Financial
Download

2017 – 2018

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (October to December)
Financial
Download
Q4 (January to March)
Financial
Download

2016 – 2017

Q1 (April to June)
Financial
Download
Q2 (July to September)
Financial
Download
Q3 (October to December)
Financial
Download
Q4 (January to March)
Financial
Download

>

  • Financials
  • Shareholding Pattern
  • Shareholder Information
  • Investor Contact
Copyrights Reserved 2008-2022. Naxpar Group